[Finished Printing? - Click Here to Return to Normal View]

 

 

Ohio Valley Node


The Ohio Valley Node includes 16 community treatment programs in Illinois, Indiana, Iowa, Kentucky, Minnesota, Missouri, Ohio, South Dakota, West Virginia, and Wisconsin, as well as researchers from the University of Cincinnati. The CTPs bring a large variety of substance abuse services and treat more than 54,000 patients per year. These patients live in both rural and urban areas and many are of Appalachian background.

 


Regional Research and Training Center

University of Cincinnati College of Medicine
Health Professions Building
P.O. Box 670553
Cincinnati, OH 45267-0553



Principal Investigator

Eugene Somoza, M.D., Ph.D
University of Cincinnati
3210 Jefferson Avenue
Cincinnati, OH 45220
513-487-7801 (Voice)
somoza@uc.edu



Community Treatment Programs

ARO Behavioral Healthcare, Inc.
New Berlin, WI

Community Health Center
Akron, OH

Comprehensive Addiction Services System
Toledo, OH

City/County Alcohol and Drug Program (CCADP)
Rapid City, SD

Crittenton
Kansas City, MO

East Indiana Treatment Center
Lawrenceberg, IN

Fairview Health Services
Minneapolis, MN

Fayette Companies
Peoria, IL

Gallahue Mental Health Center
Indianapolis, IN

Gibson Recovery Centers
Cape Girardeau, MO

HealthCare Alternative Systems
Chicago, IL

Jackson Recovery Centers
Sioux City, IA

Jefferson Alcohol and Drug Abuse Center
Louisville, KY

Maryhaven, Inc.
Columbus, OH

Mayo Clinic
Rochester, MN

Midtown Community Mental Health Center
Indianapolis, IN

Prestera Center for Mental Health Services, Inc.
Huntington, WV

The Crossroads Center
Cincinnati, OH


Ohio Valley Protocol Involvement
PROTOCOL0001 Buprenorphine/Naloxone for Opiate Detoxification - INpatient
PROTOCOL0002 Buprenorphine/Naloxone for Opiate Detoxification - OUTpatient
PROTOCOL0008 A Baseline for Investigating Diffusion of Innovation
PROTOCOL0012 Characteristics of Screening, Evaluation, and Treatment of HIV/AIDS, Hepatitis C Viral Infection, and Sexually Transmitted Infections in Substance Abuse Treatment Programs
PROTOCOL0013 Motivational Enhancement Therapy (MET) to Improve Treatment Utilization and Outcome in Pregnant Substance Users
PROTOCOL0014 Brief Strategic Family Therapy (BSFT) For Adolescent Drug Abusers
PROTOCOL0015 Women's Treatment for Trauma and Substance Use Disorders
PROTOCOL0018 Reducing HIV/STD Risk Behaviors: A Research Study for Men in Drug Abuse Treatment
PROTOCOL0019 Reducing HIV/STD Risk Behaviors: A Research Study for Women in Drug Abuse Treatment
PROTOCOL0028 Osmotic-Release Methylphenidate for ADHD in Adolescents with Substance Use Disorders
PROTOCOL0029 A Pilot Study of Osmotic-Release Methylphenidate in Initiating and Maintaining Abstinence in Smokers ADHD
PROTOCOL0030 Prescription Opioid Addiction Treatment Study (POATS)
PROTOCOL0031 Stimulant Abuser Groups to Engage in 12-Step (STAGE-12)
PROTOCOL0032 HIV Rapid Testing and Counseling in Drug Abuse Treatment Programs in the U.S.



 

 



NIDA Home | Site Map | Search | FAQs | Accessibility | Privacy | FOIA (NIH) | Employment | Print Version



National Institutes of Health logo_Department of Health and Human Services Logo The National Institute on Drug Abuse (NIDA) is part of the National Institutes of Health (NIH) , a component of the U.S. Department of Health and Human Services. Questions? See our Contact Information. Last updated on Tuesday, July 28, 2009. The U.S. government's official web portal